Adherence Connection for Counseling, Education, and Support (ACCESS) II

Part of paid clinical trials in The Bronx, New York.

Sponsor
NYU Langone Health
Study ID
NCT04499781
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 29 Years
Healthy Volunteers
Not accepted

Interventions

  • ACCESS II mHealth Intervention — BEHAVIORAL
    Participants in the intervention condition will use videoconferencing to connect synchronously with trained HIV+ peer health coaches who will deliver eight weekly, 60-minute cognitive behavioral, motivational sessions for improved ART adherence.
  • ACCESS II control condition — BEHAVIORAL
    Web-based HIV adherence education. Participants in the control group will connect asynchronously to a web-based HIV ART adherence education condition.

Study Details

The primary objective of the proposed clinical trial, Adherence Connection for Counseling, Education, and Support (ACCESS)-II, is to test the efficacy of ACCESS-II on antiretroviral treatment (ART) adherence and HIV-viral load in Black and Hispanic HIV-infected (HIV+) adolescents and young adults (AYA), ages 18-29 years (N=120) using a longitudinal (12 and 24 week outcomes), two-group, randomized control trial (RCT). Participants in the intervention condition will use videoconferencing to connect synchronously with trained HIV+ peer health coaches who will deliver eight weekly, 60-minute cognitive behavioral/motivational sessions for improved ART adherence. Participants in the control will connect asynchronously to a web-based HIV ART adherence education condition.

Key Dates

Start date
Feb 14, 2022
Status verified
Sep 2025
Primary completion
Jul 25, 2024
Completion
Jul 25, 2024

Study Design

Enrollment
60 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: HIV-infected youth: Intervention
    Sample population of perinatally and behaviorally, HIV-infected youth (ages 18-29 years). Characteristics of the target study population include ethnic minority, Black and Hispanic HIV+AYA; both males and females are eligible for participation.
  • Active Comparator: HIV-infected youth: control
    Sample population of perinatally and behaviorally, HIV-infected youth (ages 18-29 years). Characteristics of the target study population include ethnic minority, Black and Hispanic HIV+AYA; both males and females are eligible for participation.

Primary Outcome Measure

Self-Reported ART Adherence [ Time Frame: Baseline ]

Locations (1)

FacilityCityStateZIPSite coordinators
Jacobi Medical CenterThe BronxNew York10461-

Find similar trials in The Bronx, NY

By condition
HIV
By specialty
Infectious disease
By research site
Jacobi Medical Center· The Bronx, NY

Related Studies